Increase in B19 viral load prior to relapse of anaemia in an AIDS patient with persistent B19 infection

Journal of Infection

Volumn 43, Issue 2, 2001, Pages 150-152

  Hung, Chien Ching ^a   Lee, Kuang Lun ^a   Chen, Mao Yuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ETHAMBUTOL; IMMUNOGLOBULIN; ISONIAZID; LAMIVUDINE; PYRAZINAMIDE; RIFAMPICIN; SAQUINAVIR; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; ERYTHEMA INFECTIOSUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAINTENANCE THERAPY; MALE; MYCOBACTERIOSIS; PARVOVIRUS; PERSISTENT INFECTION; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; RELAPSE; VIRUS LOAD;

EID: 0035160119     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2001.0882     Document Type: Article

References (9)

1. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anaemia in AIDS
2. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: Use of intravenous immunoglobulin - A report of eight patients
3. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy
4. Parvovirus B19-associated red blood cell aplasia in combined immunodeficiency with normal immunoglobulins
5. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients
6. Parvovirus infection and its treatment
7. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis
8. The reconstituted immunity against persistent parvovirus B19 infection in an AIDS patient after highly active antiretroviral treatment
9. Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: Complete remission associated with highly active antiretroviral therapy